Compared to normal breast tissue, HER3 protein overexpression has been reported in 50–70% of human breast cancers [29–31] and seems to be associated with metastasis [32], tumor size, and risk of local recurrence [33]. This evidence concerns the gene ERBB3 and neoplasm.